Sign in

You're signed outSign in or to get full access.

Kathleen Crusco

Director at CALIXCALIX
Board

About Kathleen Crusco

Independent director (age 60), on the CALIX Board since 2017. Serves as Audit Committee Chair and is designated an “audit committee financial expert.” Prior roles include CFO/COO posts across enterprise software and technology; Bachelor of Science in Business Administration (accounting) from California State University, Chico .

Past Roles

OrganizationRoleTenureCommittees/Impact
Kony, Inc.EVP & CFODec 2017–Jan 2020Led finance operations through sale to Temenos
Epicor SoftwareEVP, COO & CFOAug 2016–Nov 2017Operational rigor at enterprise software scale
Activant SolutionsSVP & CFOMay 2007–Nov 2010Pre-merger finance leadership
PolycomVP, Worldwide Finance2002–2007Global finance leadership
Documentum; Adaptec; Price WaterhouseVarious finance rolesBuilt foundational accounting/finance expertise

External Roles

OrganizationRoleCommitteesNotes
TD Synnex CorporationDirectorAuditCurrent public company board; audit committee member

Board Governance

  • Independence: Board determined Crusco is independent under NYSE and SEC rules; seven of nine directors independent .
  • Committees: Audit (Chair; financial expert), Strategic (Member) .
  • Attendance: In 2024, Board met 6 times; each director attended ≥75% of Board and committee meetings; executive sessions held at 4 regular meetings .
  • Committee activity (2024): Audit met 11 times; Strategic met 4; Nominating & Governance 5; Talent & Compensation 6; Cybersecurity 4 (Crusco chairs Audit and sits on Strategic) .
  • Lead Independent Director: Kevin Peters (since Aug 2024) .

Fixed Compensation

ComponentPolicy YearAmountEvidence
Base Board Retainer2024$50,000
Audit Committee Chair2024$35,000
Strategic Committee (Member)2024$5,000
2024 Cash Total (Crusco)2024$90,000Matches Director Compensation table
Base Board RetainerEffective Apr 1, 2025$60,000March 2025 amendment
Audit Committee ChairEffective Apr 1, 2025$35,000
Strategic Committee (Member)Effective Apr 1, 2025$5,000
Annualized Cash (post-amendment)Effective Apr 1, 2025$100,000Components as above

Performance Compensation

YearAward TypeGrant ValueSharesVestingCIC Treatment
2024Stock Options$182,75439,478100% vests at earlier of 1-year anniversary or day before next AGMNon-employee director options accelerate upon change in control
2025 (effective at AGM)Restricted Stock Awards (RSAs)$200,000 per initial/annual grant100% vest at earlier of 1-year anniversary or day before next AGM (subject to service)Plan provides director award limit increase to $1.5M if Proposal 2 approved; CIC mechanics per plan
  • Director equity framework: Non-employee director awards capped at grant date fair value of $750,000 (proposed increase to $1,500,000 under Plan amendment) .

Other Directorships & Interlocks

  • Interlocks/related-party exposure: No related person transactions >$120,000 disclosed for 2024; policy requires Audit Committee review and prohibits director participation in approvals where conflicted .

Expertise & Qualifications

  • Financial/accounting expertise; designated Audit Committee financial expert; seasoned operator in enterprise software and technology .
  • Education: BS in Business Administration (accounting), CSU Chico .

Equity Ownership

HolderCommon Stock (#)Options Exercisable ≤60 Days (#)Total Beneficial (#)% Outstanding
Kathleen Crusco54,70539,47894,183<1% (*)
  • Stock ownership guidelines: Directors must hold ≥4x annual Board cash retainer; company states all directors are in compliance (shares from annual grants held until guidelines met) .
  • Pledging/hedging: Hedging and margin purchases prohibited; directors may pledge stock only with prior General Counsel approval; employees prohibited from pledging; no dividends on unvested awards .

Insider Trades (recent filings)

Filing DateTransaction DateFormDescriptionSource
2025-05-122025-05-08Form 4Annual stock award reported (director grants converted to RSAs in 2025; issuer form reflects stock award)
2024-05-132024-05-08Form 4Annual director equity grant reported (2024 director awards were options)

Compensation Committee Analysis

  • Composition: All independent directors; 2024 members Bowick (Chair), Makagon, Mukherjee; met 6 times; no interlocks or insider participation; no members were officers/employees .
  • Consultant: Compensia advised on plan share increase; analysis covered burn rate, overhang, market norms; committee emphasized performance-based option grants and best-practice features (no repricing, minimum vesting, clawbacks) .

Governance Assessment

  • Strengths
    • Independent director with deep finance background; Audit Chair; designated financial expert; strong committee cadence (Audit met 11× in 2024) .
    • Attendance and engagement: ≥75% meeting attendance; executive sessions held regularly; lead independent director structure in place .
    • Alignment: Director stock ownership guidelines (4× cash retainer) and reported compliance; equity awards vest over a year; no dividends on unvested awards .
    • Controls: Robust related-party policy; no related-person transactions in 2024; hedging prohibited; clawback policies adopted (2019 and Dodd-Frank-compliant in 2023) .
  • Watch items / potential red flags
    • Director pledging permitted with prior approval (no indication Crusco has pledged; monitor for future filings) .
    • Increase of director equity award limit to $1.5M under the Amended 2019 Plan (actual practice remains $200k annual grant; higher cap could enable exceptional grants—monitor usage) .

Overall signal: Crusco’s governance profile supports investor confidence—independence, audit leadership, and strong attendance—while CALIX’s director pay structure has shifted to RSAs, enhancing ownership alignment with time-based vesting and guidelines enforcement .